Purchase suggestions:
The company mainly provides health insight solutions to meet the sales and marketing needs of customers of medical product manufacturers. These solutions are mainly based on the company's retail data, which accounts for the majority of healthy big data. The market size of China's health industry grew at a compound annual growth rate of 11.6% from 16 to 21, and is expected to grow at a compound annual growth rate of 12.3% from 21 to 26. The current digital penetration rate of China's health industry is low, only 4.6%. According to iResearch, the size of China's digital health market will reach 3.055 trillion yuan by 30 years. Digital penetration is expected to rise to 11.8% in 25 years and 21.1% in 30 years. The company is in a leading position in the medical products and channel division. Health insight solutions refer to products or service products based on medical big data and related technologies, which can support the information and digital needs of organizations in the industry. Partner pharmacies are important business partners who mainly provide retail data, which form a key part of the database. The company mainly delivers solutions through offline channels in the form of reports, releases, events and events. According to iResearch Consulting report, based on 21 years of revenue and the 20-year list of top medical product manufacturers based on Torreya and Pharmaceutical Intelligence Network, the company ranks first in terms of China Health Insight Solutions Medical products and Channel Division in terms of the number of top medical product manufacturers and enterprise customers served in the past 20 years. According to the application scenario, the medical products and channels division (with a market capitalization of about 8.2 billion yuan) is one of the three major divisions of China's health insight solutions market (with a market capitalization of about 24.9 billion yuan). In terms of revenue, it accounted for about 32.9% of China's health insight solutions in 21 years, and the company ranked fifth. According to the iResearch Consulting report, the market for Chinese medical products and channels and health insight solutions is relatively fragmented, while in terms of 21-year revenue, the company accounts for about 3.9% of the market share (of which there are about 8 to 1000 market participants) and 1.3% (of which more than 2500 market participants). The capital demand of China's health industry exceeded 9 trillion yuan in 21 years, an increase of 14.6 percent over the same period last year, with in-hospital medical and health care services accounting for the largest proportion, followed by out-of-hospital and Internet health care services. The company's business model is supported by three core pillars, namely (I) Sinohealth Engine, which is a technology and data platform that supports all business segments and improves the efficiency and consistency of our product development through a set of general application modules and technologies, and includes a data warehouse. Developers can quickly combine these technologies into functions or products with terminal Value for Users. (ii) A network of participants in the health industry, including corporate organization and management, providing participants with business and connectivity opportunities, promoting products and understanding customers' business needs for new product development, a number of revenue-generating events and media channels And (iii) big data and artificial Intelligence Lab, which supports the company's R & D team focusing on data and artificial intelligence technology and providing comprehensive technology to Sinohealth Engine through internal research work and cooperation with external parties.
The company achieved operating income of 178 million yuan, 202 million yuan and 324 million yuan respectively from 19 to 21, with profits of 54.4 million yuan, 65.3 million yuan and 72 million yuan respectively, and net interest rates of about 30.6%, 32.3% and 22.2%, respectively. the R & D expenditure during the period was 2926.2 yuan, 3982.1 yuan and 2697 yuan respectively.
With an estimated market capitalization of HK $24.12 to HK $3.132 billion after listing, the company is the largest provider of health insight solutions for medical products and channels in China. The forerunner in the health insight solution industry who benefits from the strong liquidity of vertically integrated solutions for the health industry is advised to apply carefully.